| 52.57 Real-Time Quote | +0.48 / +0.92%Today’s Change | 41.12 Today|||52-Week Range 58.41 | +6.59% Year-to-Date |
| Big Things Are Happening at This Pharmaceutical Company 11:37am / MotleyFool.com | Stocks Market News for May 30, 2013 - Market News May 30 / Zacks.com |
| Billionaire Jim Simons' Buy Ups 10:52am / MotleyFool.com | Encouraging Data from Alkermes - Analyst Blog May 29 / Zacks.com |
| Sarissa's Stake in VIVUS Points to Renewed Interest in the Company Jun 06 / MotleyFool.com | Smithfield fails to light up Wall St May 29 / FT.com |
| Pfizer's Big Chance Jun 06 / MotleyFool.com | Oncogenex to Advance OGX-427 Development - Analyst Blog May 24 / Zacks.com |
| Profiting from Diabetes Expenses Jun 05 / MotleyFool.com | Priority FDA Review for Celgene's Abraxane - Analyst Blog May 24 / Zacks.com |
| Celgene Presents Data at ASCO - Analyst Blog Jun 05 / Zacks.com | US doctors paid $1bn by top drug companies May 22 / FT.com |
| Eli Lilly's Alimta Disappoints - Analyst Blog Jun 04 / Zacks.com | Big Cap Pharma Is Turning Up May 14 / StockTwits |
| Patent Challenge from Perrigo - Analyst Blog May 31 / Zacks.com |